Medistim ASA (0OCD.L) LSE

Currency In NOK

AD

Medistim ASA

Address

Økernveien 94

Oslo, 0579

Norway

Phone

47 23 05 96 60

Sector

Healthcare

Industry

Medical - Devices

Employees

154

First IPO Date

December 30, 2015

Key Executives

NameTitlePayYear Born
Kari Eian KrogstadChief Executive Officer & President4.87M1964
Jonas TyssoChief R&D Officer551,567N/A
Monica WeisethVice President of QA\Reg558,934N/A
Helge BorslidVice President of Operations1.7MN/A
Ole Jorgen RobsrudManaging Director of 3rd party distribution1.78MN/A
Ole Arne EiksundChief Business Development Officer1.85M1967
Hakon GrotheChief Innovation Officer1.88MN/A
Hæge Johanne Krogh WetterhusVice President of Marketing1.91M1964
Thomas JakobsenChief Financial Officer2.33M1969
Mike KarimChief Commercial Officer3.09MN/A
AD

Description

Medistim ASA, established in Oslo, Norway, in 1984, specializes in the innovation, production, servicing, leasing, and global distribution of sophisticated medical devices primarily for cardio-vascular surgical applications. Their market reach extends across the United States, Europe, Asia, and other international regions. A core offering is their MiraQ system, which comes in two distinct configurations: MiraQ Cardiac, specifically engineered for heart surgeries, and MiraQ Vascular, tailored for operations on blood vessels. Both versions seamlessly combine advanced ultrasound imaging with transit time flow measurement (TTFM) capabilities. The company further provides an array of imaging probes for intraoperative use, alongside a diverse selection of flow probes. These include QuickFit TTFM probes, designed for accurate intraoperative measurement of blood volume flow across various surgical scenarios; Vascular TTFM probes, aimed at improving surgical outcomes; and Doppler probes, utilized on the surface of the heart or vessels to identify intramural coronary arteries or precisely locate and quantify the severity of stenoses. Additionally, Medistim engages in the distribution and sales of third-party medical equipment.

AD